Citron Research tweeted on July 19 that AbbVie is the next great drug short. $ABBV the next great drug short. TGT price $60 Gottlieb’s comments for biosimilars and the removal of safe harbor is a DIRECT hit on Abbvie’s abuse… Read More
Is AbbVie the Next Big Drug Short?
